Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Oracle Corporation’s (ORCL) U.S. Securities and Exchange Commission filings, giving investors a primary source of information on the company’s governance, capital structure, and material events. Oracle’s common stock, par value $0.01 per share, is registered under Section 12(b) of the Exchange Act and listed on the New York Stock Exchange under the symbol ORCL, as disclosed in multiple Forms 8‑K.
Among Oracle’s key filings are current reports on Form 8‑K, which document events such as quarterly financial results, cash dividend declarations, leadership and board changes, and significant financing transactions. Recent 8‑K filings describe press releases announcing fiscal quarter results, the declaration of cash dividends on Oracle’s common stock, the promotion of executives to Chief Executive Officer roles and Principal Financial Officer, the appointment and retirement of directors, and the issuance of senior notes under an existing shelf registration statement.
Oracle’s definitive proxy statement on Schedule 14A (DEF 14A) outlines matters for its annual meeting of stockholders, including the election of directors, an advisory vote on executive compensation, and ratification of its independent registered public accounting firm. The proxy statement also discusses board structure, committees, corporate governance guidelines, stock ownership policies, and executive compensation programs.
Investors may also find Form 25 filings relevant for specific Oracle debt securities. Oracle has filed a Form 25‑NSE relating to the removal from listing of its 3.125% Notes due 2025 from the New York Stock Exchange. This filing concerns a class of notes and is separate from the listing of Oracle’s common stock.
On Stock Titan, Oracle’s SEC filings are organized chronologically and can be paired with AI‑powered summaries that explain the purpose and implications of each document. This helps readers quickly understand items such as 8‑K event descriptions, proxy proposals, and capital markets transactions, while still allowing direct access to the full text of Oracle’s submissions to the SEC.
Oracle Corporation executive Stuart Levey reported a routine equity accrual related to his compensation. On 01/23/2026, he received 337.783 restricted stock units as an "A"-coded acquisition. These units represent dividend equivalents accrued on earned restricted stock units originally granted on November 5, 2022, which he has elected to defer. The number of dividend equivalents was calculated using Oracle's closing stock price of $177.16 on the dividend payment date. Following this transaction, Levey beneficially owns 159,494.982 derivative securities in the form of restricted stock units, held directly.
Oracle Corp executive Douglas A. Kehring, EVP and Principal Financial Officer, reported selling 35,000 shares of Oracle common stock on January 15, 2026 at a price of $194.89 per share. The sale was made pursuant to a Rule 10b5-1 trading plan that was adopted on October 9, 2025, which allows pre-arranged trading according to preset terms.
Following this transaction, Kehring reports 33,638 shares of Oracle common stock held directly. He also reports an additional 2,157.514 units of Oracle common stock indirectly through the company’s 401(k) plan, where his interest is represented by units in a common stock fund rather than individual shares.
An Oracle insider filed a notice of proposed stock sales under Rule 144, covering up to 35,000 shares of common stock. The shares are to be sold through Fidelity Brokerage Services on or about 01/15/2026 on the NYSE, with an aggregate market value of $6,821,150.00 based on the figures provided. Oracle had 2,873,130,000 shares of common stock outstanding, giving context for the relative size of this planned sale.
The shares listed for sale were recently acquired through restricted stock vesting from the issuer, including 3,539 shares vested on 09/19/2025 and 31,461 shares vested on 09/20/2025 as compensation. By signing the notice, the selling party represents that they are not aware of any undisclosed material adverse information about Oracle’s current or prospective operations.
Oracle Corporation reported that two long-serving members of its Board of Directors have retired. On January 5, 2026, George H. Conrades, age 86, informed the Board that he is retiring as a director effective immediately after 18 years of service to Oracle. On January 7, 2026, Naomi O. Seligman, age 87, also notified the Board that she is retiring as a director effective immediately after 20 years of service.
Oracle stated that neither retirement was the result of any dispute or disagreement with the company on matters related to its operations, policies or practices, indicating that these departures are described as voluntary retirements following long tenures on the Board.
Oracle Corp executive Mark Hura reported two recent transactions in Oracle stock. On 12/22/2025, he made a bona fide gift of 5,000 shares of common stock to a donor advisory fund. Following that gift, he held 249,077 shares directly. On 12/24/2025, he sold 15,000 shares of Oracle common stock in open-market trades at a weighted average price of $196.8876 per share, with individual trades ranging from $196.87 to $196.93. After this sale, he directly owned 234,077 Oracle shares. Hura is identified as an officer of Oracle, serving as President, Global Field Operations.
An affiliate of Oracle Corporation has filed a notice of proposed sale of restricted stock under Rule 144. The filing covers the potential sale of 15,000 shares of common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $2,953,314.24. The approximate sale date is listed as 12/24/2025.
The shares were acquired as compensation through restricted stock vesting on 09/20/2025 from the issuer. The filing notes that there were 2,873,130,000 shares of this class outstanding at the time referenced, providing context for the relative size of the planned transaction.
Oracle Corporation insider Jeffrey Henley, a director and Vice Chairman, reported a change in how he holds some of his Oracle common stock. On December 23, 2025, he transferred 199,071 shares of common stock from his family trust to the Jeffrey & Judy Henley 1989 Trust. The filing states that he believes this transfer is a change in the form of beneficial ownership that is exempt under Rule 16a-13 of the Securities Exchange Act of 1934.
After the transaction, Henley reported indirect beneficial ownership of 1,200,910 shares by trust, 145,114 shares by a GRAT, and 362,029 shares by the Henley Community Property Trust. The reported transaction price is listed as $0, reflecting that this was a restructuring of ownership between related trusts rather than an open-market trade.
Oracle Corp director Naomi O. Seligman reported selling 2,223 shares of Oracle common stock at a price of $196.61 per share on 12/23/2025. After this transaction, she beneficially owned 25,596 shares directly, 6,000 shares indirectly through her spouse, and 14,414 shares indirectly through a trust. The filing indicates this was a routine insider transaction reported by a single reporting person.
Oracle Corp's chief executive officer, Clayton M. Magouyrk, reported a sale of company stock. On 12/19/2025, he sold 10,000 shares of Oracle common stock in an open market transaction at a weighted average price of $192.5152 per share. The filing notes that the trade was executed in multiple transactions at prices ranging from $192.48 to $192.625, with the reported price reflecting the weighted average.
Following this sale, Magouyrk beneficially owned 144,030 shares of Oracle common stock in direct ownership. The reporting person has undertaken to provide full trade details, including the number of shares and specific prices for each trade, to the SEC staff, Oracle, or any Oracle security holder upon request.
Oracle insider Naomi Seligman filed a Rule 144 notice to sell 2,223 shares of Oracle common stock through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $437,064.03. These shares were acquired on 05/31/2022 via restricted stock vesting from the issuer as compensation.
The notice also reports that Seligman sold 2,222 Oracle common shares on 09/26/2025 for gross proceeds of $641,958.24. Oracle had 2,873,130,000 common shares outstanding, providing context for the size of these transactions.
FAQ
What is the current stock price of Oracle (ORCL)?
What is the market cap of Oracle (ORCL)?
